{"id":52660,"date":"2024-10-29T08:36:15","date_gmt":"2024-10-29T06:36:15","guid":{"rendered":"https:\/\/www.fyb.de\/aignostics-raises-usd-34-million-in-series-b-financing\/"},"modified":"2024-10-30T18:36:15","modified_gmt":"2024-10-30T16:36:15","slug":"aignostics-raises-usd-34-million-in-series-b-financing","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/","title":{"rendered":"Aignostics raises USD 34 million in Series B financing"},"content":{"rendered":"

Berlin \u2014 YPOG has advi\u00adsed global arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company Aigno\u00adstics on its recent $34 million Series B funding round. The round was led by ATHOS, with invest\u00adments from Mayo Clinic and growth funding from HTGF. Aigno\u00adstics also recei\u00adved support from exis\u00adting inves\u00adtors inclu\u00adding Welling\u00adton Part\u00adners, Boeh\u00adrin\u00adger Ingel\u00adheim Venture Fund, CARMA Fund and the VC Fund Tech\u00adno\u00adlogy mana\u00adged by IBB Ventures. To date, Aigno\u00adstics has raised over $55 million, demons\u00adt\u00adra\u00adting inves\u00adtor confi\u00addence in the company\u2019s unique AI models and well-defi\u00adned commer\u00adcial stra\u00adtegy. Aigno\u00adstics was foun\u00added in 2018 and emer\u00adged in 2020 as a spin-off from Charit\u00e9 and the Berlin Insti\u00adtute of Health. The AI company trans\u00adforms complex multi\u00admo\u00addal patho\u00adlo\u00adgi\u00adcal data into valuable insights. Follo\u00adwing the closing of the latest funding round, Aigno\u00adstics plans to deve\u00adlop new product offe\u00adrings for biophar\u00admaceu\u00adti\u00adcal custo\u00admers, drive growth in the US and deve\u00adlop advan\u00adced basic models for patho\u00adlogy in colla\u00adbo\u00adra\u00adtion with the Mayo Clinic. The new funding will streng\u00adthen Aigno\u00adstics\u2019 capa\u00adbi\u00adli\u00adties in target funding, trans\u00adla\u00adtio\u00adnal rese\u00adarch and compa\u00adn\u00adion diagno\u00adstics (CDx) and support various stra\u00adte\u00adgic initia\u00adti\u00adves. \u201c2024 was a pivo\u00adtal year for us, which included an important stra\u00adte\u00adgic colla\u00adbo\u00adra\u00adtion with Bayer and the launch of our first basic model, RudolfV,\u201d said Viktor Matyas, CEO and co-foun\u00adder of Aigno\u00adstics<\/strong>. \u201cWith Rudolf, we have gained the ability to rapidly deve\u00adlop cost-effec\u00adtive algo\u00adrithms that can be trans\u00adfer\u00adred to the real world. With this new round of funding, we are turning our most popu\u00adlar algo\u00adrithms into products that will help usher in an era of truly gene\u00adra\u00adlizable AI for compu\u00adta\u00adtio\u00adnal patho\u00adlogy.\u201d About Aigno\u00adstics
\n<\/strong>
\n Aigno\u00adstics is an arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company that turns complex multi\u00admo\u00addal patho\u00adlogy data into trans\u00adfor\u00adma\u00adtive insights. By combi\u00adning proprie\u00adtary access to multi\u00admo\u00adda\u00adlity clini\u00adcal data, indus\u00adtry-leading tech\u00adno\u00adlo\u00adgies and rigo\u00adrous science, Aigno\u00adstics deve\u00adlops world-class products and services for the next gene\u00adra\u00adtion of precis\u00adion medi\u00adcine. Through colla\u00adbo\u00adra\u00adtion with its biopharma part\u00adners, Aigno\u00adstics supports drug disco\u00advery, trans\u00adla\u00adtio\u00adnal rese\u00adarch, clini\u00adcal trials and CDx deve\u00adlo\u00adp\u00adment. Foun\u00added in 2018, Aigno\u00adstics is a spin-off of Charit\u00e9 Berlin, one of the largest and most renow\u00adned univer\u00adsity hospi\u00adtals in the world. Aigno\u00adstics is funded by leading inves\u00adtors and has offices in Berlin and New York. www.aignostics.com. <\/p>\n

Advi\u00adsor Aigno\u00adstics: YPOG<\/strong><\/p>\n

Dr. Martin Scha\u00adper (Lead, Corporate\/Transactions), Part\u00adner, Berlin Dr. Jonas von Kalben (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Berlin, Anja Schind\u00adler (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Berlin, Bene\u00addikt Kreu\u00adder (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Berlin, Dr. Jacob Schrei\u00adber (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Munich About YPOG<\/strong>
\nYPOG is a specia\u00adlist law firm for tax and commer\u00adcial law, active in the core areas of funds, tax, banking + finance and tran\u00adsac\u00adtions. The YPOG team advi\u00adses a wide variety of clients.<\/p>\n

These include emer\u00adging tech\u00adno\u00adlogy compa\u00adnies and family-run medium-sized enter\u00adpri\u00adses as well as corpo\u00adra\u00adti\u00adons and private equity\/venture capi\u00adtal funds. YPOG is one of the leading addres\u00adses for venture capi\u00adtal, private equity and fund struc\u00adtu\u00adring in Germany. Today, YPOG employs more than 150 expe\u00adri\u00aden\u00adced lawy\u00aders, tax consul\u00adtants, tax specia\u00adlists and a notary in four offices in Berlin, Hamburg, Colo\u00adgne and Munich. www.ypog.de<\/p>\n","protected":false},"excerpt":{"rendered":"

Berlin \u2014 YPOG has advi\u00adsed global arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company Aigno\u00adstics on its recent $34 million Series B funding round. The round was led by ATHOS, with invest\u00adments from Mayo Clinic and growth funding from HTGF. Aigno\u00adstics also recei\u00adved support from exis\u00adting inves\u00adtors inclu\u00adding Welling\u00adton Part\u00adners, Boeh\u00adrin\u00adger Ingel\u00adheim Venture Fund, CARMA Fund and the VC [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":52658,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-52660","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\nAignostics raises USD 34 million in Series B financing - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Berlin - Global artificial intelligence (AI) company Aignostics has raised over 34 million dollars in its latest Series B funding round. The round was led by ATHOS, with investments from Mayo Clinic and growth funding from HTGF. Aignostics also received support from existing investors including Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund and VC Fonds Technologie, managed by IBB Ventures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aignostics raises USD 34 million in Series B financing - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Berlin - Global artificial intelligence (AI) company Aignostics has raised over 34 million dollars in its latest Series B funding round. The round was led by ATHOS, with investments from Mayo Clinic and growth funding from HTGF. Aignostics also received support from existing investors including Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund and VC Fonds Technologie, managed by IBB Ventures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-29T06:36:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-30T16:36:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"463\" \/>\n\t<meta property=\"og:image:height\" content=\"355\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Aignostics raises USD 34 million in Series B financing\",\"datePublished\":\"2024-10-29T06:36:15+00:00\",\"dateModified\":\"2024-10-30T16:36:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\",\"url\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\",\"name\":\"Aignostics raises USD 34 million in Series B financing - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg\",\"datePublished\":\"2024-10-29T06:36:15+00:00\",\"dateModified\":\"2024-10-30T16:36:15+00:00\",\"description\":\"Berlin - Global artificial intelligence (AI) company Aignostics has raised over 34 million dollars in its latest Series B funding round. The round was led by ATHOS, with investments from Mayo Clinic and growth funding from HTGF. Aignostics also received support from existing investors including Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund and VC Fonds Technologie, managed by IBB Ventures.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg\",\"width\":463,\"height\":355,\"caption\":\"Dr. Martin Schaper, Partner bei YPOG in Berlin (Foto\u00a9YPOG)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aignostics raises USD 34 million in Series B financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aignostics raises USD 34 million in Series B financing - FYB Financial Yearbook","description":"Berlin - Global artificial intelligence (AI) company Aignostics has raised over 34 million dollars in its latest Series B funding round. The round was led by ATHOS, with investments from Mayo Clinic and growth funding from HTGF. Aignostics also received support from existing investors including Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund and VC Fonds Technologie, managed by IBB Ventures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/","og_locale":"en_US","og_type":"article","og_title":"Aignostics raises USD 34 million in Series B financing - FYB Financial Yearbook","og_description":"Berlin - Global artificial intelligence (AI) company Aignostics has raised over 34 million dollars in its latest Series B funding round. The round was led by ATHOS, with investments from Mayo Clinic and growth funding from HTGF. Aignostics also received support from existing investors including Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund and VC Fonds Technologie, managed by IBB Ventures.","og_url":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2024-10-29T06:36:15+00:00","article_modified_time":"2024-10-30T16:36:15+00:00","og_image":[{"width":463,"height":355,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Aignostics raises USD 34 million in Series B financing","datePublished":"2024-10-29T06:36:15+00:00","dateModified":"2024-10-30T16:36:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/"},"wordCount":488,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/","url":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/","name":"Aignostics raises USD 34 million in Series B financing - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg","datePublished":"2024-10-29T06:36:15+00:00","dateModified":"2024-10-30T16:36:15+00:00","description":"Berlin - Global artificial intelligence (AI) company Aignostics has raised over 34 million dollars in its latest Series B funding round. The round was led by ATHOS, with investments from Mayo Clinic and growth funding from HTGF. Aignostics also received support from existing investors including Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund and VC Fonds Technologie, managed by IBB Ventures.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/10\/martin-schaper-ypog-ypog-1.jpg","width":463,"height":355,"caption":"Dr. Martin Schaper, Partner bei YPOG in Berlin (Foto\u00a9YPOG)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/aignostics-raises-usd-34-million-in-series-b-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Aignostics raises USD 34 million in Series B financing"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=52660"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52660\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/52658"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=52660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=52660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=52660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}